Ventricular Tachycardia (VT) Ablation Versus Enhanced Drug Therapy (VANISH)
This study is currently recruiting participants.
Verified February 2013 by Capital District Health Authority, Canada
Sponsor:
John Sapp
Collaborators:
St. Jude Medical
Biosense Webster, Inc.
Information provided by (Responsible Party):
John Sapp, Capital District Health Authority, Canada
ClinicalTrials.gov Identifier:
NCT00905853
First received: May 20, 2009
Last updated: February 20, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2014 |
| Estimated Primary Completion Date: | May 2014 (Final data collection date for primary outcome measure) |